Indian health officials have ordered a maker of cough syrups to halt production after they were linked to the deaths of over 70 children in Gambia.
The World Health Organization issued a global alert over four of Maiden’s cough syrups that were linked to the deaths in Gambia.
The global health organization also warned the products may have been distributed, through informal markets, to other countries and regions, besides The Gambia.
“Maiden pharmaceuticals broke rules across its manufacturing and testing activities, in view of the seriousness of the contraventions observed during the investigation and its potential risk to the quality, safety and efficacy of the drug being produced,” WHO added.
The manufacturing activities were suspended in the New-Delhi based firm after regulators found several safety rules had been broken.
Maiden had at first failed to comment on the claims but later said it was shocked to hear media reports regarding the deaths and deeply saddened by this incident.
The President of Gambia Adama Barrow said authorities would “leave no stone unturned” in their investigation.
Gambians are demanding justice for the loss of lives, which has had police forces launch investigations on the same.
Also Read: Sudan Schools Crisis Threatens Grim Future for Children